-+ 0.00%
-+ 0.00%
-+ 0.00%

Co-Diagnostics JV Reports HPV Study Finds High-Grade Lesions or Cancer in 12 of 20 HPV-Positive Women

PUBT·10/29/2026 13:07:21
Listen to the news
Co-Diagnostics JV Reports HPV Study Finds High-Grade Lesions or Cancer in 12 of 20 HPV-Positive Women
  • Co-Diagnostics announced publication of a peer-reviewed study using its Indian joint venture CoSara Diagnostics' SARAGENE high-risk HPV test.
  • Follow-up biopsies identified high-grade cervical lesions or invasive cervical cancer in HPV-positive women, despite predominantly negative cytology results.
  • Investigators described the findings as preliminary, citing study design and limited HPV-positive participants; larger studies are needed to confirm the results.
  • The laboratory-based test is authorized for testing in India but is not available for sale in the United States.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA84263) on October 29, 2026, and is solely responsible for the information contained therein.